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Background: Cigarette smoking is the leading cause of chronic obstructive pulmonary
disease. (-)-Epigallocatechin-3-gallate (EGCG), the major catechins in Chinese green
tea, has been studied for its anti-oxidative and anti-inflammatory properties in cell and
animal models. In this study, we aimed to analyze the effects of EGCG on cigarette
smoke (CS)-induced airway inflammation and mucus secretion in the CS-exposed rat
model.
Methods: Male Sprague-Dawley rats were randomly divided into either sham air
(SA) or CS exposure. EGCG (50 mg/kg b.wt.) was given by oral gavage every
other day in both SA and CS-exposed animals. Oxidative stress and inflammatory
markers were determined in serum and/or bronchoalveolar lavage fluid by biochemical
assays or ELISA. Lung morphological changes were examined by Periodic Acid-Schiff,
Masson’s Trichrome staining and immunohistochemical analysis. Western blot analysis
was performed to explore the effects of EGCG on epidermal growth factor receptor
(EGFR)-mediated signaling pathway.
Results: (-)-Epigallocatechin-3-gallate treatment attenuated CS-induced oxidative
stress, lung cytokine-induced neutrophil chemoattractant-1 release and neutrophil
recruitment. CS exposure caused an increase in the number of goblet cells in line with
MUC5AC upregulation, and increased lung collagen deposition, which were alleviated
in the presence of EGCG. In addition, CS-induced phosphorylation of EGFR in rat lung
was abrogated by EGCG treatment.
Conclusion: (-)-Epigallocatechin-3-gallate treatment ameliorated CS-induced oxidative
stress and neutrophilic inflammation, as well as airway mucus production and collagen
deposition in rats. The present findings suggest that EGCG has a therapeutic effect
on chronic airway inflammation and abnormal airway mucus production probably via
inhibition of EGFR signaling pathway.
Keywords: cigarette smoke, (-)-epigallocatechin-3-gallate, epidermal growth factor receptor, inflammation,
mucus secretion, neutrophil infiltration
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INTRODUCTION
Chronic obstructive Pulmonary Disease (COPD) is a healthcare
issue aﬄicting more than 600 million people worldwide,
estimated to become the third leading cause of death by
the year 2020 (Murray and Lopez, 2013). COPD, which
is characterized by the development of irreversible airflow
obstruction, is associated with chronic inflammation, leading
to progressive decline in lung function (Ito and Barnes, 2009).
Exposure to cigarette smoke (CS) is widely attributed to be
the major cause of COPD, with accumulation of oxidant
burden and airway mucus hypersecretion being pivotal in the
pathogenesis of the disease (Macnee, 2007). CS is composed
of a complex cocktail of chemicals, able to produce in excess
of 1015 oxidants per puff (Church and Pryor, 1985). In
homeostatic settings, natural antioxidative defenses involving
enzymes such as catalases (CAT), superoxide dismutase (SOD),
and glutathione s-transferase (GST) would be mounted to
combat the oxidative stress elicited by CS exposure (Schieber
and Chandel, 2014). Many markers of oxidative stress have
been used to describe the effects of cigarette smoking and have
been linked to development of COPD including 8-isoprostane,
total-antioxidant capacity (T-AOC), and advanced oxidation
protein products (AOPP) (Kinnula, 2005; Tavilani et al., 2012;
ben Anes et al., 2014). In COPD, mucus hypersecretion has
an important influence on small airways, which would further
block the existing narrow and obstructed airways, leading to
deterioration of lung function. Airway mucus hypersecretion is
characterized by goblet cell hyperplasia and metaplasia lining
the airway epithelium. Mucin synthesis and secretion in the
airways have been reported to be regulated by activation
of the epidermal growth factor receptor (EGFR) (Ha and
Rogers, 2016). However, there are currently no satisfactory
treatments for mucus overproduction, which would help with
the alleviation of airway obstruction and the clinical outcomes of
COPD.
Chinese green tea consumption has been associated with
many beneficial health effects, as we previously demonstrated
that Chinese green tea can reduce CS-mediated lung injury
in rats (Chan et al., 2009). The beneficial effects of green tea
are attributed to the high abundance in phenolic catechins,
with the main subtypes being (-)-epigallocatechin-3-gallate
(EGCG), (-)-epicatechin-3-gallate (ECG), (-)-epigallocatechin
(EGC) and (-)-epicatechin (EC). EGCG is by far the most
abundant catechin found in green tea, which can make up
to 0.05% of the total content of tea by weight (Higdon and
Frei, 2003). Catechins possess strong antioxidant properties,
with EGCG and ECG having the highest antioxidant activity,
followed by EGC and then EC (Nanjo et al., 1999). Catechins
are also thought to possess immunomodulatory properties
(Higdon and Frei, 2003). In a mouse smoking model, EGCG
partially suppressed BALF inflammatory cells and lactate
dehydrogenase activity (March et al., 2006). In airway epithelial
cells, EGCG was also found to inhibit release of CS-induced pro-
inflammatory cytokines through inhibition of NF-κB activation
(Syed et al., 2007). However, there have been few studies
regarding the effects of EGCG on mucin 5AC (MUC5AC)
overproduction and other pathological alterations such as
fibrosis in the airways in vivo, and the mechanisms by
which EGCG regulate MUC5AC expression have yet to be
elucidated.
In the present study, we investigated the effects of EGCG on
CS-induced airway inflammation and mucus hypersecretion and
the associated signaling pathway using a CS-exposed rat model.
MATERIALS AND METHODS
Materials
Purified EGCG (>95%) was kindly provided by Dr. Hara
Yukihiko of Tea Solution, Hara Office Inc. (Tokyo, Japan).
Camel cigarettes (with filter, 11 mg tar, 0.8 mg nicotine)
were purchased commercially (R.J. Reynolds, Winston-Salem,
NC, United States). The bioassay kits of total anti-oxidant
capacity (T-AOC), enzyme activity of total superoxide dismutase
(SOD) and glutathione s-transferase (GST) were purchased
from Nanjing Jiancheng Bioengineering Institute (Nanjing,
Jiangsu, China) and enzyme activity of catalase (CAT)
was from Molecular Probes Inc., Invitrogen (Eugene, OR,
United States). The enzyme-linked immunosorbent assay
(ELISA) kits for 8-isoprostane, cytokine-induced neutrophil
chemoattractant-1 (CINC-1, resembles to human IL-8) and
monocyte chemotactic protein-1 (MCP-1, CCL2) were
purchased from Cayman (Ann Arbor, MI, United States),
R&D systems (Minneapolis, MN, United States) and BD
Biosciences (San Jose, CA, United States) respectively. Periodic
Acid-Schiff (PAS) and Masson’s Trichrome staining systems
were purchased from Sigma–Aldrich Co. LLC (St. Louis, MO,
United States).
Animal Treatment
Male Sprague-Dawley rats (220–260 g) were exposed to cigarette
smoke using a home-made system previously established by our
group (Chan et al., 2009; Lau et al., 2012). Animals were placed
in a 20-liter Perspex chamber, under a constant stream of CS (4%
v/v, smoke/air) passed through the chamber for 1 h daily, for 56
consecutive days. Rats were randomly divided into four groups:
sham air with water (SA group), cigarette smoke exposure with
water (CS group), sham air with EGCG (50 mg/kg body weight)
by oral gavage every other day (EGCG/SA group), and cigarette
smoke exposure with EGCG (50 mg/kg body weight) by oral
gavage every other day (EGCG/CS group). The dose of EGCG
used in this study was chosen based on previously published
data (Chan et al., 2010). All studies were approved by the
Committee on the Use of Live Animals in Teaching and Research
(CULATR, No. 2702-12) at the University of Hong Kong. All
animals were purchased from the Laboratory Animal Unit at the
University of Hong Kong. Animals were housed in a controlled
environment (22 ± 1◦C), humidity (65–70%) on a 12/12-h
light/dark cycle.
Approximately 24 h after the last CS exposure, the body
weight of rats was measured and the animals were euthanized
with lethal dose (100 mg/kg body weight) of phenobarbital
for blood and tissue harvesting. An incision was made at the
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upper part of the trachea and bronchoalveolar lavage (BAL)
was collected by instilling lungs with 1.5 ml ice-cold phosphate
buffer saline (PBS) for three times in total. The BAL was
centrifuged at 3,000 rpm for 15 min and the supernatant
was collected as bronchoalveolar lavage fluid (BALF). Serum
was separated by centrifugation at 1,500 g for 10 min.
Serum, BALF and lung tissues were stored at −80◦C until
use.
Histological and Morphometric Analyses
The largest lobe of the left lung tissue was fixed in
4% formalin solution and embedded in paraffin (Chan
et al., 2009). Paraffin-embedded blocks of lung tissues
were cut to 5-µm thickness using a microtome, and the
deparaffinized tissue sections were subjected to PAS staining
to identify goblet cells or Masson’s Trichrome to identify
collagen deposition. Images of 5 fields for epithelium
in cartilaginous bronchus were captured randomly at
×20 magnifications by using a Nikon Eclipse Ni (Nikon
Instruments Inc., Tokyo, Japan) with a SPOT RT3 camera
(Model 25.4 2 Mp Slider, SPOT Imaging Solutions, Sterling
Heights, MI, United States). The PAS-positive areas were
measured using the SPOT Software 5.0. Quantification
of the Masson’s Trichrome staining was analyzed by
Image J (NIH) with additional threshold color plug-ins
to process the file images in tiff. Pixels corresponding to
the area stained in blue for Masson’s Trichrome staining
were normalized to the total pixel area of the tissue
image and the results were expressed as positive area (%).
Images were analyzed by two independent and blinded
investigators.
Measurement of Oxidative Stress and
Inflammatory Markers
Serum AOPP level was determined as previously described
(Lau et al., 2012). AOPP level is expressed in µM chloramine-
T equivalents. Serum level 8-isoprostane and activities of
T-AOC, SOD, CAT and GST were assayed by commercially
available kits. The measurement of T-AOC was based on the
ferric reducing/antioxidant power (FRAP) method as previously
described (Qiao et al., 2006). One unit of T-AOC is defined as
the OD value of the reaction system increase 0.01 per minute at
37◦C. One unit of total SOD activity is defined as the amount
of enzyme needed to exhibit 50% dismutation of the superoxide
radical in 1 ml reaction buffer. One unit of CAT activity is
defined as the amount of enzyme that will decompose 1 µmole
of H2O2 per minute at pH 7.0 at 25◦C. One unit of GST
activity is defined as 1 µmole of GSH decreased per minute
under the conditions of 37◦C. Serum and BALF levels of CINC-
1 and MCP-1 were determined with commercially available
kits.
Western Blot Analysis
Frozen lung tissues were homogenized using mortar and pestle
as previously described (Chan et al., 2009). Supernatants were
assayed for protein concentration by Bradford method using
bovine serum albumin as standard. Lung proteins (40 µg)
were separated on 10% SDS–PAGE and then transferred
onto a nitrocellulose membrane. After blocking in 5% non-
fat milk, membranes were incubated with diluted specific
primary antibodies (p-EGFR: #YP0526, EGFR: #YT1485,
ImmunoWay Biotechnology Company, Plano, TX, United States;
FIGURE 1 | Effect of EGCG on serum oxidative stress markers in rats. 8-isoprostane level (A) and advanced oxidation protein products (AOPP) level (B) were
significantly increased in CS-exposed group of rats compared to SA group. Oral administration of EGCG significantly decreased 8-isoprostane and AOPP levels
compared to CS group. Total antioxidant capacity (T-AOC) (C), total superoxide dismutase (SOD) activity (D), and catalase (CAT) activity (E) were inhibited in
CS-exposed rats while EGCG treatment reversed these enzymes activities. CS exposure upregulated the activity of glutathione s-transferase (GST) and EGCG
treatment reversed GST activity (F). The results are expressed as means ± SEM; n = 7 each group. SA group, water/sham air; CS group, water/cigarette smoke;
EGCG/SA group, EGCG (50 mg/kg)/sham air; EGCG/CS, EGCG (50 mg/kg)/cigarette smoke. ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗p < 0.001 for the comparison between
CS and SA group, #p < 0.05, ##p < 0.01 and ###p < 0.001 for the comparison between EGCG/CS and CS group.
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β-actin: #4970, Cell Signaling Technology Inc., Danvers, MA,
United States) overnight at 4◦C. Then the membranes were
incubated with horseradish peroxidase (HRP)-conjugated
goat-anti-rabbit IgG secondary antibodies (Novus Biologicals,
Littleton, CO, United States) and visualized by medical X-ray
film using enhanced chemiluminescence (ECL; Amersham
Biosciences, Piscataway, United Kingdom). Densitometry
analysis of the bands was performed using ImageJ.
Immunohistochemistry and
Immunohistofluorescent Staining
The deparaffinized and hydrated lung section was placed
in a 10 mM citric acid solution (pH6.0) and incubated at
120◦C for 10 min. Sections were cooled to room temperature
and then washed with PBS for 10 min. After blocking with
10% house serum in antibody diluent for 1 h, sections were
stained with the primary antibody (MUC5AC) overnight
at 4◦C and then incubated with ImmPRESSTM Universal
Reagent anti-mouse/rabbit IgG peroxidase (Vector Laboratories,
Burlingame, CA, United States) for 1 h. Diaminobenzidine
(DAB) (Pierce Biotechnology, Thermo Fisher Scientific,
Waltham, MA, United States) was prepared according to
the manufacturer, and 100 µl of solution was added to each
section for 3–5 min. Sections were then rinsed in distilled
water and underwent conventional dehydration and then
mounted. The extent of MUC5AC-positive staining in each
airway was analyzed following the same method as PAS
staining.
After rehydration and blocking as described above, lung
sections were stained with primary antibody (neutrophil elastase,
NE, ab21595; Abcam, Cambridge, MA, United States) overnight
at 4◦C and then incubated with fluorescence-labeled secondary
antibody and mounting medium containing DAPI (Invitrogen).
The imaging analysis was performed by counting number
of positive cells and the total amount of nuclei in each
field. The ratio of positive cells to the total cell number
is calculated to avoid the effect of cell density in lung
sections.
Statistical Analysis
Results are expressed as means ± SEM. For comparisons
between groups, analysis of variance (ANOVA) with
Bonferroni post hoc analysis was used. All analyses were
performed using Prism (Version 6.0, GraphPad, San Diego,
FIGURE 2 | Effects of EGCG on CINC-1 and MCP-1 levels in serum and BALF of rats. Both CINC-1 and MCP-1 levels in serum and BALF were significantly elevated
in the rats exposed to CS for 56 days (A–D). EGCG attenuated CS-induced CINC-1 elevation in serum (A) and BALF (C) and reduced serum MCP-1 level (B) but
not BALF MCP-1 level (D). The results are expressed as means ± SEM; n = 7 each group. SA group, water/sham air; CS group, water/cigarette smoke; EGCG/SA
group, EGCG (50 mg/kg)/sham air; EGCG/CS, EGCG (50 mg/kg)/cigarette smoke. ∗p < 0.05 and ∗∗∗p < 0.001 for the comparison between CS and SA group,
#p < 0.05 for the comparison between EGCG/CS and CS group.
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CA, United States), with a value of p < 0.05 regarded as
significant.
RESULTS
Effects of EGCG on Cigarette Smoke
(CS)-Induced Oxidative Stress
Levels of oxidative stress markers, including 8-isoprostane
and AOPP, were elevated by CS in serum compared to SA
group (p < 0.05 and p < 0.01 for CS and SA groups,
respectively). EGCG treatment reversed CS-induced elevation
of serum levels of 8-isoprostane and AOPP to SA group
(p < 0.01 and p < 0.001, respectively). EGCG treatment alone
had no effect on serum levels of 8-isoprostane and AOPP levels
(Figures 1A,B).
Cigarette smoke exposure reduced the serum T-AOC
and the activities of antioxidant enzymes such as SOD
and CAT (p < 0.01 for CS and SA groups, respectively),
which was blocked by EGCG administration (T-AOC:
p < 0.01; SOD: p < 0.001; and CAT: p < 0.05)
(Figures 1C–E).
Serum GST activity was elevated to more than twofolds after
CS exposure (p < 0.001 for CS and SA groups, respectively),
which was inhibited in the presence of EGCG (p < 0.05)
(Figure 1F).
Effects of EGCG on CS-Induced Lung
Inflammation
Cigarette smoke elevated levels of inflammatory chemokines
CINC-1 and MCP-1 (Figure 2), in serum and BALF (p < 0.05
for serum CINC-1 and MCP-1, p < 0.001 for BALF CINC-1 and
MCP-1 for CS and SA groups, respectively). EGCG attenuated
the CS-induced elevation of CINC-1 in both serum and BALF
(p < 0.05, respectively), while EGCG attenuated the CS-induced
elevation of MCP-1 in serum (p < 0.05) but not in BALF
(p > 0.05).
Effect of EGCG on CS-Induced
Neutrophil Infiltration in Rat Lung
To examine the infiltration of neutrophils in the lung, lung
sections were immunostained with NE (Figure 3A). CS exposure
increased the number of infiltrated neutrophil as NE-positive
cells in the lung (p < 0.001 for comparison between CS and SA
FIGURE 3 | Effect of EGCG on neutrophil infiltration in rat lung. Rats treated with EGCG or control vehicle were killed on day 57 and the left lung was formalin-fixed
and sectioned for immunofluorescence (magnification ×400). (A) Representative immunofluorescence images of tissue neutrophils as neutrophil elastase
(NE)-positive cells with green fluorescence in lung sections. Nuclei were stained with DAPI in blue fluorescence. Scale bar, 50 µm. Arrows indicate representative
cells with positive staining. (B) Quantification of NE-positive cells in the lung sections. The results are expressed as means ± SEM; n = 6 each group. SA group,
water/sham air; CS group, water/cigarette smoke; EGCG/SA group, EGCG (50 mg/kg)/sham air; EGCG/CS, EGCG (50 mg/kg)/cigarette smoke. ∗p < 0.05 and
∗∗∗p < 0.001 for the comparison to SA group, ###p < 0.001 for the comparison between EGCG/CS and CS group.
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groups). EGCG treatment reduced the number of neutrophils
significantly (p < 0.001) (Figure 3B).
Effect of EGCG on CS-Induced Mucus
Hypersecretion
To confirm the effect of EGCG on airway mucus hypersecretion
in CS-exposed rat, the lung section was stained with PAS
(Figure 4A). CS exposure significantly caused upregulation of the
number of goblet cells containing mucus in the epithelial surface
of cartilaginous bronchus (p < 0.001). Treatment with EGCG
significantly reduced the number of goblet cells (p < 0.001)
(Figure 4C).
MUC5AC is recognized as the major secreted airway
mucins, which is highly expressed in the goblet cells of
the airway epithelium. Immunohistochemical experiment
showed that the MUC5AC-positive cells were co-localized
in PAS-stained goblet cells (Figure 4B). The MUC5AC-
positive staining in airway epithelium was increased in
CS-exposed rat (p < 0.001), which was abolished by EGCG
administration (p < 0.001) (Figure 4D). Therefore, EGCG could
inhibit CS-induced mucus hypersecretion in the airways of
rats.
Effect of EGCG on CS-Induced Lung
Fibrosis
Small airway remodeling is a common feature of COPD patients.
The sub-epithelial deposition of collagen in airways of medium
size indicates fibrosis. Masson’s Trichrome staining was used to
evaluate the presence and the distribution of the collagen in the
lung (Figure 5A). CS increased collagen deposition in and around
the airway wall in the lungs compared to SA group (p < 0.001).
In the EGCG/CS group, the collagen deposition significantly
reduced compared to CS group (p < 0.001) (Figure 5B).
Involvement of EGFR in EGCG Action
against CS-Induced Mucus Secretion
To further explore the mechanism how EGCG ameliorated CS-
induced mucus hypersecretion, the changes of protein expression
of p-EGFR and EGFR were detected using Western blot analysis.
CS exposure upregulated the expressions of p-EGFR and EGFR
FIGURE 4 | Effect of EGCG on airway mucus secretion in rats. Rats treated with EGCG or control vehicle were killed on day 57 and the left lung was formalin-fixed
and sectioned for histology/immunohistochemistry (magnification ×200). (A) Representative photomicrographs of lung sections stained with periodic acid Schiff
(PAS). Goblet cells appear as purple staining (arrows) over epithelium. PAS staining revealed increased goblet cell metaplasia after CS exposure and EGCG reduced
the CS-induced goblet cell metaplasia. (B) Immunohistochemistry for MUC5AC was performed using an anti-MUC5AC peptide mouse polyclonal antibody, and
detected with an anti-mouse/rabbit IgG peroxidase antibody and diaminobenzidine (DAB). MUC5AC-positive staining showed similar phenomenon of mucus
secretion of PAS-staining in different groups. Scale bar, 100 µm. Arrows indicate representative cells with positive staining. (C) Quantification of PAS-positive cells per
length of epithelium for goblet cells of different groups. (D) Quantification of MUC5AC-positive cells per length of epithelium for mucin of different groups. The results
are expressed as means ± SEM; n = 5–6 each group. SA group, water/sham air; CS group, water/cigarette smoke; EGCG/SA group, EGCG (50 mg/kg)/sham air;
EGCG/CS, EGCG (50 mg/kg)/cigarette smoke. ∗∗∗p < 0.001 for the comparison to SA group, ###p < 0.001 for the comparison between EGCG/CS and CS group.
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by 4.5- and 2.8-fold, respectively, and increased the ratio
of p-EGFR/EGFR significantly, which were inhibited in the
presence of EGCG treatment to the same extent (Figure 6 and
Supplementary Figure S1).
DISCUSSION
In this study, we demonstrated that the imbalance of serum levels
of oxidants and antioxidants by CS exposure was reversed by
EGCG administration, in support of EGCG being an antioxidant.
We further found that EGCG inhibited CS-induced goblet
cell hyperplasia and reduced number of MUC5AC-positive
cells in the airways, CINC-1 production, neutrophil infiltration
and collagen deposition probably via the inhibition of EGFR
activation in rat lung. To the best of our knowledge, this is the
first study to reveal the signaling pathway involved in EGCG-
mediated inhibition of mucus hypersecretion in vivo.
In contrast to our previous study, Chinese green tea (Lung
Chen) caused body weight loss (Chan et al., 2009) but not EGCG
treatment. At baseline, the body weight was similar among all
groups. By week 8, the weight gain in the CS group was slightly
lower than in the SA group (data not shown). Therefore, the loss
of body weight from green tea should be due to the presence of
the combination of catechins rather than EGCG alone.
In the current study, serum 8-isoprostane, a biomarker of
oxidative stress, was increased after CS exposure in agreement
with COPD patients and animal studies (Chan et al., 2009;
Kazmierczak et al., 2015). Another oxidative stress biomarker
AOPP, as a measure of protein oxidation caused by the
chlorinated oxidants, was associated with the status of smoking
in humans (Vargas et al., 2013), in agreement with our current
findings. In response to the increase in oxidant load, we found
a decrease in serum T-AOC, and a reduction in activities of
both SOD and catalase upon CS exposure. In agreement, T-AOC
in saliva was reduced in smokers compared with non-smokers
(Bakhtiari et al., 2015), and the activities of SOD and catalase,
the most important antioxidant enzymes, were reduced in serum
of smokers and COPD patients compared to normal controls
(Tavilani et al., 2012). GSTs, phase II enzymes that catalyze the
conjugation of electrophilic molecules with glutathione (GSH) to
detoxified conjugates were increased in mild COPD patients but
reduced in severe COPD patients (Harju et al., 2008) compared
to normal controls. In this study, we found an increase in serum
GST levels after CS exposure, indicating that our animal model
mimics milder stages of human COPD. Similar to our previous
findings with Chinese green tea (Lung Chen), we found that
the pure compound EGCG could effectively reverse CS-induced
imbalance on oxidants/antioxidants, supporting the role of green
tea catechin EGCG in controlling oxidative stress.
Smoking is regarded as one of major risk factors in chronic
inflammatory lung diseases. Components of CS have strong
oxidative effects and are believed to drive the downstream
inflammatory processes, especially in the small airways (Hogg,
FIGURE 5 | Effect of EGCG on airway fibrosis in rats. Rats treated with EGCG or control vehicle were killed on day 57 and the left lung was formalin-fixed and
sectioned for histology (magnification ×200). (A) Representative photomicrographs of lung sections stained with Masson’s Trichrome staining system. More collagen
deposition/fibrosis in or near the airway wall was found in CS group compared to SA group. Compared with the CS group, collagen deposition in the EGCG/CS
group was significantly reduced. Scale bar, 100 µm. (B) Quantification of staining-positive area (%) of the lung sections from different group. The results are
expressed as means ± SEM; n = 5–6 each group. SA group, water/sham air; CS group, water/cigarette smoke; EGCG/SA group, EGCG (50 mg/kg)/sham air;
EGCG/CS, EGCG (50 mg/kg)/cigarette smoke. ∗∗∗p < 0.001 for the comparison between CS and SA group, ###p < 0.001 for the comparison between EGCG/CS
and CS group.
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2004). A variety of inflammatory and immune cells, including
macrophages, neutrophils, CD8+ lymphocytes, and their release
of multiple inflammatory mediators were involved in such
process (Barnes, 2004). Our previous study also demonstrated
that CS caused infiltrations of macrophages and neutrophils
in the airways (Li et al., 2017). In this study, we focused on
CINC-1 (resemble to human IL-8) and MCP-1, which regulate
the recruitment and maturation of neutrophils and macrophages,
respectively. Higher gene expression levels of IL-8 and MCP-1
were found in the bronchiolar epithelium of subjects with
COPD (de Boer et al., 2000) and increased levels of IL-8 in
sputum and BALF of patients with COPD compared with healthy
smokers (Keatings et al., 1996; Tanino et al., 2002). Upon CS
exposure, both CINC-1 and MCP-1 were upregulated in serum
and BALF. Interestingly, EGCG administration reduced the
levels of CINC-1 in both serum and BALF, but not MCP-1 in
BALF (Figure 2), suggesting the presence of differential effects.
The exact mechanism in which EGCG mediates such an effect
may be due to direct binding to the chemokines and limiting
their biological activities (Qin et al., 2011). The mechanism for
the differential effects between serum and BALF MCP-1 was
currently unclear. In this study, EGCG was administered via oral
FIGURE 6 | Effect of EGCG on the activation of EGFR in rats.
(A) Representative photographs of Western blot for p-EGFR and EGFR
proteins from homogenized rat lung tissue were shown. (B) Protein levels
were normalized to the corresponding β-actin and the ratios of p-EGFR/EGFR
were calculated. Western blot analysis showed that EGCG suppressed
CS-induced elevated phosphorylation of EGFR, total EGFR and the ratio of
p-EGFR/EGFR. The results are expressed as means ± SEM; n = 7 each
group. SA group, water/sham air; CS group, water/cigarette smoke;
EGCG/SA group, EGCG (50 mg/kg)/sham air; EGCG/CS, EGCG
(50 mg/kg)/cigarette smoke. ∗∗∗p < 0.001 for the comparison between CS
and SA group, #p < 0.05, ##p < 0.01, ###p < 0.001 for the comparison
between EGCG/CS and CS group. EGFR, epidermal growth factor receptor.
gavage with its active ingredients absorbed into the blood stream.
Neutrophils are recruited into the lung from the circulation via
CINC-1 as chemoattractant. On the other hand, there are two
types of macrophages found in the lung, i.e., resident alveolar
macrophages and macrophages differentiated from circulating
monocytes. MCP-1 plays a critical role in regulating the activation
and recruitment of cells of the monocytic lineage. Therefore,
the predominant resident alveolar macrophages may not be an
essential target of EGCG via oral gavage to detect an inhibitory
effect on MCP-1 in BALF. Although there was no inhibition of
CS-induced elevation of MCP-1 in BALF, EGCG significantly
inhibited CS-mediated recruitment of neutrophils, in line with
the inhibition of CINC-1 in both serum and BALF.
Mucus is essential because of its role in protecting the airways.
However, chronic inflammatory lung diseases, such as COPD,
are often associated with excessive mucus production, especially
in cases of chronic bronchitis. Cigarette smoke is a common
stimulus that promotes mucus secretion and has a great effect
on promoting the synthesis and secretion of MUC5AC mucin
(Haswell et al., 2010). MUC5AC has been recognized as the
predominant mucin in human airway epithelial cells, and its
expression increases in smokers and patients with COPD (Di
et al., 2012). In this study, CS exposure caused increased numbers
of goblet cells and the MUC5AC-positive cells in the airways
of rats as an indicator for the production of more mucus
due to oxidative stress. In agreement, oxidants were found
to be involved in mucus hypersecretion and impairment of
mucociliary clearance (Fischer et al., 2015). Hydrogen peroxide
and superoxide were shown to cause increased mucus secretion
in airway epithelial cells (Adler et al., 1990). Our data revealed
that EGCG reversed the activities of SOD and CAT, which
could reduce the levels of hydrogen peroxide and superoxide,
resulting in attenuation of mucus production, which may suggest
the partial attribution of antioxidative effect of EGCG on
mucus secretion. On the other hand, excessive neutrophilia and
neutrophil chemoattractants, like IL-8 and CINC-1/GRO-α, have
been linked to the development of the mucus hypersecretory
phenotype present in COPD patients (Nadel, 2000). Neutrophils
are the predominant inflammatory cells in the airways of
patients with COPD. Neutrophilic products, such as proteases
and oxidants, have been evaluated for their roles in regulating
mucin gene expression. NE, a serine protease, is regarded as
a major product from activated neutrophils to be implicated
in airway inflammation, goblet cell metaplasia, structural lung
damage, and host defense (Gehrig et al., 2014). NE, which
can then act directly on the epithelium (Takeyama et al.,
2000), increases MUC5AC gene expression by inducing oxidative
stress (Fischer and Voynow, 2000) or releasing transforming
growth factor (TGF)-α, which results in EGFR activation (Kohri
et al., 2002). In the present study, the neutrophil counts were
elevated in CS-exposed rats and significantly lowered in EGCG-
pretreated rats. Therefore, the inhibitory effect of EGCG on
mucus hypersecretion may be partly due to the inhibition of
neutrophil infiltration.
The EGFR signaling pathway is a receptor tyrosine kinase
and plays a regulatory role in airway mucus production and
secretion (Ha and Rogers, 2016). Takeyama et al. (2000) found
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FIGURE 7 | Schematic diagram. Cigarette smoke (CS) exposure causes oxidative stress, inflammation, and airway mucus production. (-)-Epigallocatechin-3-gallate
(EGCG) attenuated CS-induced oxidative stress, neutrophilic airway inflammation, and airway mucus production in rat lungs probably via the inhibition of epidermal
growth factor receptor (EGFR) signaling pathway, leading to amelioration of airway remodeling.
that ligand-independent EGFR phosphorylation occurred in
response to oxidative stress induced by activated neutrophils.
Furthermore, Takeyama demonstrated that CS exposure
upregulated EGFR mRNA expression and induced EGFR-
specific tyrosine phosphorylation, resulting in increased
MUC5AC mRNA and protein production, such effects that
were inhibited completely by selective EGFR tyrosine kinase
inhibitors (Takeyama et al., 2001). In this study, CS increased
the neutrophil infiltration in the airways, increased p-EGFR and
EGFR protein levels in rat lung tissue, resulting in increased
MUC5AC production, which was inhibited in the presence of
EGCG, indicating the protective effect on CS-mediated airway
mucus hypersecretory diseases through the EGFR pathway. In
support of our findings, the theaflavins isolated from black tea
and ECG extracted from green tea have been reported to inhibit
mucin secretion possible via EGFR pathway (Kim et al., 2010;
Wu et al., 2012).
Pulmonary fibrosis is a hallmark of repeated cycles of
dysregulated repair and remodeling of the lung parenchyma,
causing decreased airway elasticity. The role of fibrosis in COPD
is somewhat controversial but recent evidence suggests that
fibrosis and COPD do co-exist, usually in smokers (Jankowich
and Rounds, 2012). Collagen fibers, being one of the main
components of the extracellular matrix, undergo constant
remodeling upon injury caused by exposure to CS (McKleroy
et al., 2013). Increased collagen deposition was found to correlate
with lung destruction in human emphysema (Martin-Mosquero
et al., 2006). In this study, rats exposed to CS increased collagen
deposition in the lung, which was attenuated by EGCG treatment.
The exact mechanisms involved are not entirely clear, although
some studies have inferred that catechins are potentiating
stabilization of collagen fibers as well as the inhibition of
collagenases (Madhan et al., 2005, 2007).
CONCLUSION
Our data demonstrate that EGCG has a protective effect on
CS-induced oxidative stress, airway neutrophilic inflammation,
and airway mucus production in rat lungs probably via inhibition
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of EGFR signaling pathway, leading to amelioration of airway
remodeling (Figure 7). EGCG may be a promising therapeutic
strategy to limit neutrophil recruitment and to treat mucus
hypersecretion in the airways of smokers without or with COPD.
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